Objective-Reverse cholesterol transport comprises efflux of cholesterol from macrophages and its subsequent removal from the body with the feces and thereby protects against formation of atherosclerotic plaques. Because of lack of suitable animal models that allow for evaluation of the respective contributions of biliary cholesterol secretion and transintestinal cholesterol excretion (TICE) to macrophage reverse cholesterol transport under physiological conditions, the relative importance of both pathways in this process has remained controversial. Approach and Results-To separate cholesterol traffic via the biliary route from TICE, bile flow was mutually diverted between rats, continuously, for 3 days. Groups of 2 weight-matched rats were designated as a pair, and both rats were equipped with cannulas in the bile duct and duodenum. Bile from rat 1 was diverted to the duodenum of rat 2, whereas bile from rat 2 was rerouted to the duodenum of rat 1. Next, rat 1 was injected with [ 3 H]cholesterol-loaded macrophages. [
U ptake of low-density lipoprotein particles by macrophages in the vessel wall via scavenger receptors 1 and pinocytosis 2 causes the formation of foam cells and thereby gives rise to atherosclerotic cardiovascular disease. Accumulated intracellular cholesterol can be removed via the reverse cholesterol transport (RCT) pathway that mediates efflux of cholesterol from macrophages and its subsequent elimination from the body. Thereby RCT can protect against the development and progression of atherosclerotic plaques. 3 Detailed knowledge about the processes underlying RCT is imperative for successful development of therapeutic intervention strategies. Secretion of cholesterol by the liver into the bile and its subsequent excretion with the feces used to be regarded the sole route to dispose cholesterol from the body, but more recently another pathway has been shown to mediate cholesterol removal directly from the blood in a nonbiliary fashion. 4 Although the exact mechanisms driving the cholesterol flux through the so-called transintestinal cholesterol excretion (TICE) pathway have to date remained incompletely understood, it is now broadly accepted that TICE mediates mobilization of substantial amounts of cholesterol. 5, 6 TICE accounts for ≈35% of fecal cholesterol removal in humans. 7 In mice, TICE contributes about 30% to fecal cholesterol excretion under nonstimulated conditions but can be potently stimulated, for example, by LXR (liver X receptor) and FXR (Farnesoid X receptor) agonists, as well as plant sterols. 4, 8, 9 Liver-derived apolipoprotein (apo) B-containing lipoproteins may deliver cholesterol to the basolateral side of enterocytes for uptake via the low-density lipoprotein receptor and other receptors. 6 After intracellular trafficking to the apical side via poorly defined mechanisms, cholesterol is effluxed into the intestinal lumen via ATP-binding cassette transporters G5 and G8 8 and, conceivably, ABCB1a/b. 10 Whether or not TICE is also involved in macrophage RCT has been fervidly debated. Whereas some studies report that macrophage RCT is almost exclusively mediated via the hepatobiliary route, [11] [12] [13] others suggest that it is mainly mediated via TICE.
14 Results reported to date were either obtained in genetic models in which normal hepatic cholesterol fluxes were severely perturbed 11, 12, 14 or in bile duct ligation models 11, 13 lacking phospholipid/bile acid mixed micelles in the intestine that are essential for functional TICE. 15 These deviations from normal physiology conceivably explain the contrasting results, stressing the need for more suitable animal models. In this study, we assessed the respective contributions of biliary cholesterol secretion and TICE to macrophage RCT, under physiological conditions, using an approach in which bile is mutually exchanged between unanesthetized rats for prolonged periods of time.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
To separate cholesterol traffic via the biliary route from TICE, bile flow was mutually exchanged between rats ( Figure 1 ; Methods in the online-only Data Supplement). Groups of 2 weight-matched rats were designated as a pair, and both rats were surgically equipped with cannulas in the bile duct and duodenum. 16 Bile from rat 1 was diverted to the duodenum of rat 2, whereas bile from rat 2 was rerouted to the duodenum of rat 1. Under these circumstances, both rats had an essentially natural delivery of phospholipid/bile acid micelles into the intestine. Next, rat 1 was injected with [ (Figure 2A ). Because cholesterol is the substrate for bile acid synthesis, macrophage-derived 3 H-label can be transferred to those molecules during their synthesis. Bile acids can freely circulate between the rats in this model and therefore transfer radiolabel from one rat to another. As the time needed for enterohepatic cycling of bile acids is only 2 to 3 hours, 16 labeled bile acids are rapidly distributed over both rats of a pair during bile exchange. However, bile acids are very efficiently cleared from the circulation keeping plasma levels very low. Therefore, potential radioactivity in plasma associated with bile acids synthesized from [ 3 H]cholesterol is expected to be minimal. In contrast to plasma, bile acid concentrations in bile are high. Indeed, radioactivity in bile was predominantly because of the incorporation of tritium label into bile acids (data not shown). No overt differences in the appearance of 3 H-tracer in bile were observed ( Figure 2B ), indicating that the bile acid pools mixed well, and bile acids were successfully circulating between the rats. In line with the results obtained from plasma, significant amounts of tracer could only be recovered from livers of the macrophage-injected rats ( Figure IIIA in the online-only Data Supplement). Tracer recovery from the FNS fractions reveals the relative contribution of the hepatobiliary pathway and TICE to RCT. Of note, substantial amounts of tracer were detected within the FNS of macrophage-injected and noninjected rats, illustrating that TICE and biliary cholesterol secretion both contribute to macrophage RCT ( Figure 2C the individual pairs and data from 2 additional pairs, included in a second experiment, are shown in Figure IIIB in the onlineonly Data Supplement. Of the tracer excreted within FNS, 37% was derived from TICE and 63% from biliary cholesterol secretion as reflected by the amounts of tracer present within the FNS fractions of the injected and noninjected rats, respectively. Because tracer excreted within fecal bile acids represents an appreciable fraction of macrophage RCT ( Figure IIIC and IIID in the online-only Data Supplement), the actual contribution of TICE to total macrophage RCT is smaller ( Figure 2D ). Over 3 days, 57% of the total excreted tracer was found within FNS, whereas 43% was present as bile acid. Tracer excretion within FNS of macrophage-injected rats (ie, labeled cholesterol excreted via TICE) accounted for 21% of the total amount of excreted tracer. Because bile acids are committed to the hepatobiliary route, this pathway accounted for 79% of total macrophage RCT (ie, sum of tracer within FNS of the noninjected rat and tracer in fecal bile acids of both rats of a couple).
Discussion
Our study demonstrates that TICE and hepatobiliary cholesterol secretion both contribute to macrophage RCT under physiological conditions. Putting our results into perspective of available literature, Temel et al 14 found no difference in macrophage RCT between liver NPC1L1-transgenic (L-NPC1L1tg) mice and wild-type littermates. Because biliary cholesterol secretion was reduced by >90% in L-NPC1L1tg mice, those results suggest that macrophage RCT does not require a functional hepatobiliary cholesterol secretion pathway, and TICE mediates most of the macrophage RCT. In apparent contrast, using mice with hepatic overexpression of human NPC1L1 on an NPC1L1-deficient background, others reported results arguing against a role for TICE in RCT. 12 However, in both models, physiological hepatic cholesterol fluxes are severely disturbed, generating the possibility that adaptive mechanisms were activated. Therefore, the observations might be a result of the perturbation applied in the animal model rather than reflecting normal physiology. Results from bile duct ligation experiments suggested that only hepatobiliary sterol secretion is contributing to RCT, and that TICE does not play a role in this process. 11, 13 However, luminal secretion of cholesterol by enterocytes requires the presence of bile acid/phospholipid micelles in the intestine to facilitate this final step of the TICE pathway. 15 As a result of bile duct ligation, the mixed micelles do not reach the intestine. Therefore, in addition to the hepatobiliary route, TICE is also expected to be inhibited under those conditions, making bile duct ligation an unsuitable model to study the involvement of the TICE pathway in RCT. To circumvent the problems associated with the animal models used to date, we used an alternative approach that does allow quantitative assessment of the contribution of both pathways to (macrophage) RCT under physiological conditions. The only deviation from normal physiology in our model was the use of ezetimibe. We cannot exclude the possibility that the use of ezetimibe affected the results of this study because it can stimulate TICE. 7 The use of ezetimibe was, however, necessary to prevent intestinal reabsorption of labeled cholesterol after its secretion into the bile. Synthesis of bile acids is the major pathway of cholesterol catabolism. 17 Bile acids secreted into the feces indeed substantially contribute to total macrophage RCT. In our current experiment, 43% of the total amount of label present within feces could be attributed to bile acid synthesis.
In conclusion, using continuous bile exchange between rats, we were able to clarify the differential contribution of TICE and biliary cholesterol secretion to macrophage RCT. We demonstrate that TICE indeed functionally contributes to macrophage RCT, although the majority of this process is mediated via the hepatobiliary route under physiological conditions. It would be of interest to exploit the bile exchange model described in this study to explore whether pharmacological interventions that stimulate cholesterol disposal via TICE impact the differential contribution of this pathway and hepatobiliary cholesterol secretion to macrophage RCT.
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